In a quarter where the market preferred flashy AI tickers to unglamorous healthcare plumbing, P3 Health Partners (PIII) and Amwell (AMWL) quietly reported results that suggest the real work in healthcare is happening far from meme stocks and momentum screens. Both companies…
PACS Group, Inc. is giving Wall Street a reason to smile, with its Salt Lake City roots, NYSE ticker PACS, and a stock that is rallying smartly today while still showing solid gains over the year despite bouts of volatility.
From the Wasatch…
Amwell’s (NYSE: AMWL) first-quarter scorecard reads like a classic Wall Street turnaround chapter: the top line is shrinking, but the balance sheet is fortified, losses are tightening, and management is whistling its way toward cash-flow breakeven by year-end.
Cash, Costs and a…
Amwell’s (NYSE: AMWL) latest story is a quiet telehealth turnaround: a company that spent the last cycle building infrastructure now talking more about operating leverage, sticky SaaS, and a disciplined path to growth – all while the rest of digital health is…
UnitedHealth just got the policy equivalent of a surprise bonus check from Washington — and Wall Street is cashing it just as fast as the insurers are.
Medicare’s Big Reveal: From Nail-Biter to Tailwind
For months, Medicare Advantage insurers had been bracing…
The latest March jobs report delivered the economic equivalent of a plot twist: the US economy added 178,000 jobs while the unemployment rate fell to 4.3%, confounding forecasts that had braced for a far softer print. Instead of signaling a labor market…
Blackstone (BX) and TPG (TPG) are taking women’s health leader Hologic Inc. (HOLX) private in one of the largest healthcare buyouts of 2025, valuing the Massachusetts-based company at up to $18.3 billion including debt. The all-cash deal, announced Tuesday, will pay Hologic…
Modular Medical (NASDAQ: MODD), a potential disruptor in diabetes care technology, is rapidly moving from visionary concept to tangible innovation as it propels its FDA cleared MODD1 insulin patch pump toward commercial launch. The company has recently validated its MODD1 cartridge manufacturing…
Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner…
